ScoreWhy is NeuroOne Medical Technologies Corp. ?
1
Poor Management Efficiency with a low ROE of 0%
- The company has reported losses. Due to this company has reported negative ROE
2
Positive results in Jun 25
- OPERATING CASH FLOW(Y) Highest at USD -4.27 MM
- NET SALES(HY) At USD 3.08 MM has Grown at 39.92%
- NET PROFIT(HY) Higher at USD -4.48 MM
3
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 11.54%, its profits have risen by 44.8%
4
Increasing Participation by Institutional Investors
- Institutional investors have increased their stake by 1.41% over the previous quarter and collectively hold 15.39% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to NeuroOne Medical Technologies Corp. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is NeuroOne Medical Technologies Corp. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
NeuroOne Medical Technologies Corp.
3.2%
-0.23
89.43%
S&P 500
13.22%
0.61
20.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
60.44%
EBIT Growth (5y)
1.49%
EBIT to Interest (avg)
-9.31
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.08
Sales to Capital Employed (avg)
1.98
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
15.39%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
25.74
EV to EBIT
-4.22
EV to EBITDA
-4.39
EV to Capital Employed
-27.76
EV to Sales
3.17
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-626.73%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bearish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend19What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -4.27 MM
NET SALES(HY)
At USD 3.08 MM has Grown at 39.92%
NET PROFIT(HY)
Higher at USD -4.48 MM
ROCE(HY)
Highest at -95.39%
RAW MATERIAL COST(Y)
Fallen by -59.79% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at -94.7 %
DEBTORS TURNOVER RATIO(HY)
Highest at 46.91 times
-4What is not working for the Company
INTEREST(9M)
At USD 0.33 MM has Grown at inf%
Here's what is working for NeuroOne Medical Technologies Corp.
Net Sales
At USD 3.08 MM has Grown at 39.92%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Net Profit
Higher at USD -4.48 MM
than preceding 12 month period ended Jun 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Operating Cash Flow
Highest at USD -4.27 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Debt-Equity Ratio
Lowest at -94.7 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Debtors Turnover Ratio
Highest at 46.91 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -59.79% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for NeuroOne Medical Technologies Corp.
Interest
At USD 0.33 MM has Grown at inf%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
